Redmile Group, LLC - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 106 filers reported holding RAPT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.4%.

Quarter-by-quarter ownership
Redmile Group, LLC ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,104,884
-12.0%
427,490
-1.0%
0.34%
+9.0%
Q2 2023$8,076,885
-36.0%
431,919
-37.2%
0.31%
-43.4%
Q1 2023$12,627,222
-18.7%
688,132
-12.3%
0.55%
-13.8%
Q4 2022$15,539,674
-17.7%
784,8320.0%0.64%
-13.1%
Q3 2022$18,883,000
+26.5%
784,832
-4.0%
0.73%
+28.4%
Q2 2022$14,925,000
-9.3%
817,832
+9.2%
0.57%
+10.9%
Q1 2022$16,463,000748,6770.51%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Ponoi Management, LLC 1,599,417$29,189,00046.08%
KPCB XV Associates, LLC 1,297,063$23,671,00043.66%
Column Group LLC 2,680,458$48,918,00010.41%
Ponoi II Management, LLC 145,401$2,654,0007.21%
Euclidean Capital LLC 432,900$7,900,0006.72%
AJU IB Investment Co., Ltd. 99,503$1,816,0003.52%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,023,321$18,676,0003.17%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 443,619$8,096,0001.62%
Ghost Tree Capital, LLC 165,000$3,011,0001.57%
Perceptive Advisors 1,913,791$34,927,0001.09%
View complete list of RAPT THERAPEUTICS INC shareholders